Rheumatology

INTRODUCTION

Fibromyalgia is a disease characterized by chronic diffuse musculoskeletal pain. The symptoms of the disease are fatigue, sleep disorder, anxiety or depression as well as gastrointestinal symptoms, such as irritable bowel or diffuse abdominal pains.  Pain that lasts more than three months is considered chronic, and pain that is located in both hemispheres of the body, is considered diffuse. Women are more likely to develop fibromyalgia than men. The therapeutic options are mainly antidepressants but also drugs for neuropathic pain, while the main goal for these patients is to reduce pain and improve sleep quality.

PRODUCT INFORMATION

Reumaspis is a specially formulated nutraceutical for the management of fibromyalgia. It has a binary effect in patients with fibromyalgia reducing the pain and tenderness and slowing the progression of the disease. Reumaspis has anti-inflammatory and antioxidant action due to the specially produced red ginseng.  The antioxidant effect is augmented by astaxanthin, providing the necessary antioxidant mechanism in the neuronal cells. Astaxanthin, which is contained in the product, is literally hundreds of times stronger than other antioxidant molecules. Astaxanthin comes from the algae of the genus Haematococcus pluvialis and is a natural carotenoid. Reumaspis has a strong anti-depressant effect. The main anti-depressant ingredient is the stigma of the plant Crocus sativus L, which is a plant with a long history and use. Finally, Reumaspis contributes to normal function of bones by supplying the body with magnesium, vitamin D3 and B12.

INTRODUCTION

Osteoarthritis or known as chronic joint degeneration, is the most common form of Arthritis. Osteoarthritis can cause cartilage degeneration and affects mainly people of advanced age. It can affect any joint of the human body, but mostly affects the joints that are strained on a daily basis (e.g., knee, hand, spine). Τhe disease shows gradually progression and according to the severity of the symptoms, is classified from stage I to stage IV (stage IV more severe). The late stages are the most severe where the symptoms are intense and daily life is becoming more and more difficult. The most common symptoms are pain, stiffness and tenderness. Existing treatment options focus on relief of pain such as injections of hyaluronic acid.

PRODUCT INFORMATION

Arthroaspis Motus is a nutritional supplement for the management of osteoarthritis stage III and IV. It reduces pain and stiffness and delays the progression of the disease. Arthroaspis Motus acts as a lubricant, relieving arthrosis from further pain. Arthroaspis Motus contains hyaluronic acid in high molecular weight, in order to secure its absorption and bioavailability. In addition, Arthroaspis Motus has a high antioxidant effect, giving in the patients a positive effect on mobility.  The eggshell membrane, which is contained in Arthroaspis Motus, is a clinically tested ingredient for its positive effect in osteoarthritis. Arthroaspis Motus has also a protective role against the oxidative stress in cartilage and plays a key role in maintaining cartilage homeostasis due to the selenium which is contained in Arthroaspis Motus. Finally, Arthroaspis Motus covers the patients’ vitamin D3 needs, which also contributes to the normal function of bones.

INTRODUCTION

Sjögren Syndrome is an autoimmune disease that affects the whole body. Its name comes from the Swedish ophthalmologist Henrik Sjögren who was the first to identify the disease. In Sjögren Syndrome the immune system mainly attacks the lacrimal and salivary glands, causing dry mouth and/or dry eyes. The syndrome mainly affects women aged 40–60. In addition to dry eyes, patients with Sjogren's disease also experience meibomianitis. What dry eye has in common with meibomianitis is the disturbance of the balance in the tear film which is characterized by inflammation and eye symptoms. Existing treatment options focus on topical relief by lubricating the cornea.

PRODUCT INFORMATION

Eyeaspis DE caps is a specially designed product that manages dry eye disease and helps to decongest clogged glands. Eyeaspis DE caps has a proven anti-inflammatory effect and provides fatty acids as the main ingredient of meibomian gland to produce the right quality and quantity of the lipid layer (meibum).

Key components of the lipid layer with a strong anti-inflammatory effect are ω-3 fatty acids such as eicosapentaenoic acid (EPA) which is essential fatty acid for general function of the organism and which the body cannot synthesize by itself.

Eyeaspis DE caps has a strong anti-inflammatory effect with the re-esterified triglyceride EPA as the main ingredient and antioxidant effect due to maqui berry extract (35% delphinidins). In addition, Eyeaspis DE caps covers the basic needs of the body in vitamin D3 with 1000 IU and vitamin B12.

INTRODUCTION

Sjögren Syndrome is an autoimmune disease that affects the whole body. Its name comes from the Swedish ophthalmologist Henrik Sjögren who was the first to identify the disease. In Sjögren Syndrome the immune system mainly attacks the lacrimal and salivary glands, causing dry mouth and/or dry eyes. The syndrome mainly affects women aged 40–60. In addition to dry eyes, patients with Sjogren's disease also experience meibomianitis. What dry eye has in common with meibomianitis is the disturbance of the balance in the tear film which is characterized by inflammation and eye symptoms. Existing treatment options focus on topical relief by lubricating the cornea.

PRODUCT INFORMATION

Eyeaspis Dry Eye is a specially designed product that manages dry eye disease and helps to express the clogged glands. Eyeaspis Dry Eye has a proven anti-inflammatory effect and provides the fatty acid as the main ingredient of meibomian gland to produce the right quality and quantity of the lipid layer (meibum). Key components of the lipid layer with a strong anti-inflammatory effect are ω-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) which are essential fatty acids for general function of the organism and which the body cannot synthesize by itself. Eyeaspis Dry Eye has a strong anti-inflammatory effect with EPA and DHA as main ingredients. In addition, Eyeaspis Dry Eye covers the basic needs of the body in vitamin D3 with 1000 IU.